| Literature DB >> 35010592 |
Iván Martín-Guzón1, Alejandro Muñoz2, Jorge Lorenzo-Calvo1, Diego Muriarte1, Moisés Marquina1, Alfonso de la Rubia1.
Abstract
Lower limb injuries are frequent in handball and a serious hindrance to athletic performance. The aim of this systematic review was to synthesize the available research on the prevalence of lower limb injuries in handball players according to sex and competitive level. According to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis, 19 studies were selected after a systematic search and selection process of three digital databases: Scopus, PubMed, and Web of Science. Furthermore, a study quality analysis using an 'Extension for Sports Injury and Illness Surveillance of the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE-SIIS)' was carried out. The sample consisted of 7110 male and female handball players registering 4483 injuries in their lower limbs. The results showed a high incidence of knee injuries (30.23%) and ankle injuries (24.80%), especially in the ligaments, such as the talofibular and the anterior cruciate ligaments. Considering sex and competitive level, knee injuries accounted for 47.02% of injuries among women, while among men, ankle injuries were most prevalent (34.22%) in international competitions. Additionally, the most common cause of injuries was trauma (85.61%). The findings highlighted that the prevalence of lower limb injuries varies greatly according to the characteristics of the sample and injury. Therefore, the study underlines the importance that sports practitioners (physical trainers, readapters, and physiotherapists) adapt training protocols to reduce injury incidence in the most affected body areas or tissues.Entities:
Keywords: ankle; body area; epidemiology; handball; injury; knee; pathology; tissue
Mesh:
Year: 2021 PMID: 35010592 PMCID: PMC8751175 DOI: 10.3390/ijerph19010332
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flow chart for screening and selection according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA).
Summary of the sample (“n”, sex, age, and competitive level) and injury characteristics (“n”, body area, tissue type, pathology type, and injury mechanism).
| Study | SAMPLE CHARACTERISTICS | INJURY CHARACTERISTICS | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
| Sex | Age | Competitive Level | Sex ( | Body Area | Tissue Type | Pathology Type | Injury Mechanism | |
| Badekas et al. [ | 75 | M | 24.0 | International (level 1) | M (1) | Thigh | Muscle | Hamstring | - |
| M (23)/W (5) | Lower Leg | Tendon | Achilles Tendon | ||||||
| M (3) | Lower Leg | Tendon | Tibialis Anterior | ||||||
| M (1) | Lower Leg | Bone | Tibia | ||||||
| M (16)/W (7) | Ankle | Ligament | Talofibular Ligaments | ||||||
| M (1)/W (2) | Ankle | Bone | Lateral Malleolus | ||||||
| M (8)/W (2) | Ankle | Tendon | Peroneal Tendon | ||||||
| M (8)/W (3) | Foot | Bone | Metatarsals | ||||||
| W (5) | Foot | Bone | 1º Metatarsal (Hallux Valgus) | ||||||
| M (2) | Foot | Bone | 1º Metatarsal (Hallux Rigidus) | ||||||
| W (1) | Foot | Bone | 5º Metatarsal | ||||||
| Vauhnik et al. [ | 258 | W | 17.7 ± 3.7 | National and TID System (levels 2 and 3) | W (6) | Knee | Ligament | Anterior Cruciate Ligament | Traumatism |
| Moller et al. [ | 125 | M | 20.5 | National and TID System (levels 2 and 3) | 37 * | Hip/Groin | Muscle | Buttocks | Traumatism |
| 5 * | Hip/Groin | Bone | Pelvis | ||||||
| 29 * | Thigh | - | - | ||||||
| 87 * | Knee | - | - | ||||||
| 53 * | Lower Leg | - | - | ||||||
| 6 * | Lower Leg | Tendon | Achilles Tendon | ||||||
| 94 * | Ankle/Foot | - | - | ||||||
| Bere et al. [ | 384 | M | - | International (level 1) | M (1) | Hip/Groin | Muscle | Buttocks | Traumatism |
| M (5) | Hip/Groin | Bone | Pelvis | ||||||
| M (21) | Thigh | Muscle | Hamstrings | ||||||
| M (15) | Knee | - | - | ||||||
| M (8) | Lower Leg | - | - | ||||||
| M (23) | Ankle | Ligament | Talofibular Ligaments | ||||||
| M (5) | Foot | Bone | Metatarsals | ||||||
| Sonnery-Cottet et al. [ | 2 | M | 25.2 | National | M (1) | Thigh | Tendon | Femoral Biceps | - |
| M (1) | Thigh | Tendon | Semitendinosus | ||||||
| Krosshaug et al. [ | 372 | W | 21.4 | National | W (26) | Knee | Ligament | Anterior Cruciate Ligament | Traumatism |
| Steffen et al. [ | 420 | W | 21.4 | National | W (28) | Knee | Ligament | Anterior Cruciate Ligament | Traumatism |
| Giroto et al. [ | 183 | M | 24.1 ± 5.0 | National | M (8)/W (10) | Hip/Groin | Muscle | Adductors/Psoas Iliacus | Traumatism |
| W (2) | Hip/Groin | Muscle | Buttocks | ||||||
| M (1)/W (2) | Hip/Groin | Bone | Pelvis | ||||||
| M (19)/W (8) | Thigh | Muscle | Hamstring | ||||||
| M (14)/W (38) | Knee | - | - | ||||||
| M (2)/W (1) | Lower Leg | Tendon | Achilles Tendon | ||||||
| M (11)/W (6) | Lower Leg | - | - | ||||||
| M (21)/W (25) | Ankle | Ligament | Talofibular Ligaments | ||||||
| M (1) | Foot | Bone | Metatarsals | ||||||
| Andersson et al. [ | 55 | M | - | International (level 1) | M (4) | Knee | Ligament | - | Traumatism |
| M (6) | Ankle | Ligament | Talofibular Ligaments | ||||||
| Luig et al. [ | 1194 | M | 25.3 ± 5.3 | National | M (240) | Hip/Groin | - | - | Traumatism |
| M (444) | Thigh | - | - | ||||||
| M (706) | Knee | - | - | ||||||
| M (331) | Lower Leg | - | - | ||||||
| M (650) | Ankle | - | - | ||||||
| M (279) | Foot | - | - | ||||||
| Von Rossen et al. [ | 20 | M | 17.0 | TID System | 4 * | Hip/Groin | - | - | - |
| 9 * | Thigh | - | - | ||||||
| 11 * | Knee | - | - | ||||||
| 8 * | Lower Leg | - | - | ||||||
| 8 * | Ankle | - | - | ||||||
| Florit et al. [ | 612 | M | 24.3 ± 6.8 | National and TID System | M (6) | Thigh | Tendon | Abductor Tendon | - |
| M (8) | Thigh | Tendon | Cuadriceps Tendon | ||||||
| M (2) | Thigh | Tendon | Hamstring Tendon | ||||||
| M (26) | Knee | Tendon | Patellar Tendon | ||||||
| M (14) | Knee | Tendon | Other Tendons | ||||||
| M (18) | Lower Leg | Tendon | Achilles Tendon | ||||||
| M (8) | Ankle | Tendon | - | ||||||
| Mónaco et al. [ | 164 | M | 15.3 ± 3.0 | National and TID System | M (35) | Thigh | - | - | - |
| M (34) | Knee | - | - | ||||||
| M (52) | Ankle | - | - | ||||||
| Rafnsson et al. [ | 109 | M | 23.4 | National | M (6) | Hip/Groin | - | - | Traumatism |
| M (2) | Thigh | - | - | ||||||
| M (21) | Knee | - | - | ||||||
| M (2) | Lower Leg | - | - | ||||||
| M (10) | Ankle | - | - | ||||||
| M (10) | Foot | - | - | ||||||
| Tabben et al. [ | 387 | M | 27.4 ± 4.4 | International (level 1) | M (3) | Hip/Groin | Muscle | Buttocks | Traumatism |
| M (1) | Hip/Groin | Bone | Adductors/Psoas Iliacus | ||||||
| M (1) | Hip/Groin | Bone | Pelvis | ||||||
| M (12) | Thigh | - | - | ||||||
| M (14) | Knee | - | - | ||||||
| M (3) | Lower Leg | - | - | ||||||
| M (18) | Ankle | - | - | ||||||
| M (1) | Foot | - | - | ||||||
| Luig et al. [ | 1899 | M | - | International and National | M (31) | Thigh | Muscle | - | Traumatism |
| M (76) | Knee | Ligament | Anterior Cruciate Ligament | ||||||
| M (24) | Knee | Ligament | Medial Collateral Ligament | ||||||
| M (62) | Ankle | Ligament | Talofibular Ligaments | ||||||
| Barič et al. [ | 81 | M | 22.6 ± 5.1 | National | W (1) | Hip/Groin | - | - | Traumatism |
| M (4)/W (10) | Knee | - | - | ||||||
| M (14)/W (18) | Ankle | - | - | ||||||
| M (3)/W (2) | Foot | - | - | ||||||
| Roh et al. [ | 96 | M | 27.1 ± 4.8 | National | M (4)/W (7) | Hip/Groin | - | - | - |
| M (31)/W (32) | Thigh | - | - | ||||||
| M (66)/W (90) | Knee | - | - | ||||||
| M (24)/W (26) | Lower Leg | - | - | ||||||
| M (31)/W (43) | Ankle | - | - | ||||||
| M (15)/W (16) | Foot | - | - | ||||||
| Szymski et al. [ | 79 | M | 26.9 ± 4.8 | National | M (9) | Hip/Groin | - | - | - |
| M (35) | Thigh | - | - | ||||||
| M (41) | Knee | - | - | ||||||
| M (40) | Ankle | - | - | ||||||
| M (13) | Foot | - | - | ||||||
Note:n = absolute frequency; M = men; W = women; “*” = no specified the sample sex; TID = talent identification and development; “-” = not codable. The number of handball players (n = 7710) did not coincide with the number of injuries (n = 4483) because the studies analyzed were not only composed of a sample of handball players or exclusively considered injuries to the lower limb.
Distribution of lower limb injuries (n y %) in handball players according to body area and tissue type.
| Tissue Type | Body Area | TOTAL | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hip/Groin | Thigh | Knee | Lower Leg | Ankle | Foot | ||||||||
|
| % |
| % |
| % |
| % |
| % |
| % | ||
| Ligament | - | - | - | - | 164 | 3.66 | - | - | 160 | 3.57 | - | - | 324 (7.23) |
| Muscle | 92 | 2.05 | 49 | 1.09 | - | - | - | - | - | - | - | - | 141 (3.15) |
| Bone | 15 | 0.33 | - | - | - | - | 1 | 0.02 | 3 | 0.07 | 25 | 0.56 | 44 (0.98) |
| Tendon | - | - | 18 | 0.40 | 40 | 0.89 | 58 | 1.29 | 18 | 0.40 | - | - | 134 (2.99) |
| Nc | 271 | 6.05 | 629 | 14.03 | 1151 | 25.67 | 472 | 10.53 | 931 | 20.77 | 386 | 8.61 | 3840 (85.66) |
| TOTAL | 378 | 8.43 | 696 | 15.53 | 1355 | 30.23 | 531 | 11.84 | 1112 | 24.80 | 411 | 9.17 | 4483 (100) |
Notes:n = absolute frequency; % = relative frequency; ‘Nc‘ = not codable.
Figure 2(a–d) Type of pathology in the lower limb based on the tissue injured.
Injury prevalence (body area) of the lower limb in handball players based on sex and competitive level.
| Body Area | M | W | ||||
|---|---|---|---|---|---|---|
| International | National | TID System | International | National | TID System | |
| Hip/Groin | 11 (0.25) | 268 (5.98) | - | - | 22 (0.49) | - |
| Thigh | 50 (1.10) | 572 (12.76) | 26 (0.57) | - | 42 (0.94) | - |
| Knee | 83 (1.85) | 939 (20.95) | 37 (0.83) | - | 195 (4.35) | 3 (0.07) |
| Lower Leg | 38 (0.85) | 379 (8.45) | 9 (0.20) | 5 (0.11) | 33 (0.74) | - |
| Ankle | 103 (2.30) | 827 (18.45) | 30 (0.67) | 11 (0.25) | 86 (1.92) | - |
| Foot | 16 (0.36) | 321 (7.16) | - | 9 (0.20) | 18 (0.40) | - |
Notes:n = absolute frequency; % = relative frequency; M = men; W = women; TID = talent identification and development; ‘-‘ = not codable.
Figure 3Production mechanism of lower limb injuries among handball players.
Study quality assessment according to the Strengthening the Reporting of Observational Studies on Injury and Illness in Sport—“STROBE-SIIS”.
| Author(s) | *1 | *2 | *3 | *4 | *5 | *6 | *7 | *8 | *9 | *10 | *11 | *12 | *13 | *14 | *15 | *16 | *17 | *18 | *19 | *20 | *21 | *22 | *23 | Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Badekas et al. [ | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 15 |
| Vauhnik et al. [ | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 18 |
| Moller et al. [ | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 14 |
| Bere et al. [ | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 17 |
| Sonnery-Cottet et al. [ | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 15 |
| Krosshaug et al. [ | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 21 |
| Steffen et al. [ | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 20 |
| Giroto et al. [ | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 19 |
| Andersson et al. [ | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 18 |
| Luig et al. [ | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 16 |
| Von Rosen et al. [ | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 17 |
| Florit et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 19 |
| Mónaco et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 22 |
| Rafnsson et al. [ | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 18 |
| Tabben et al. [ | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 18 |
| Luig et al. [ | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 18 |
| BariČ et al. [ | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 12 |
| Roh et al. [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 19 |
| Szymski et al. [ | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 15 |
Notes: ‘0′ = item with absence or lack of information; ‘1′ = item with complete and explicit information; in Title and Abstract, *1 (Title/Abstract) = include information on the sport, athlete population (sex, age, geographic region), level of competition, and the duration of observation. In Introduction, *2 (Background) = explain the scientific background and rationale for the investigation being reported. *3 (Objectives) = state whether study was registered. Identify the registration number and database used/state the specific purpose of the study. In Methods, *4 (Study Design) = present key elements of study design early in the paper; *5 (Settings) = describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection; *6 (Participants) = define the population of athletes as well as describe how they were selected and recruited; *7 (Variables) = justify why you measured your primary and secondary outcomes of interest in the specific way chosen/describe the method for identifying the health problem outcome of interest; *8 (Data Sources) = for each variable of interest, provide sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than 1 group; *9 (Bias) = clearly report any validation or reliability assessment of the data collection tools/formally acknowledge any potential biases associated with the data collection method; *10 (Study Size) = explain how the study size was arrived at; *11 (Quantitative Variables) = explain in detail how multiple injuries/illness episodes are handled both in individual athletes and across athletes/surveillance periods/specify how injury severity was calculated; *12 (Statistical Methods) = describe all the statistical methods, including those used to control for confounding/describe any methods used to examine subgroups and interactions/explain how missing data were addressed/describe any sensitivity analyses. In Results, *13 (Participants) = report numbers of individuals at each stage of study/provide the reasons for non-participation at each stage; *14 (Descriptive Data) = include details on the level of competition being observed; *15 (Outcome Data) = in observational studies, individuals will sustain more than one health problem over the surveillance period. Take care to ensure that descriptive data represent both the number of health problems and the number of athletes affected. It is important to represent effectively both the analysis and reporting of correct units for frequency data; *16 (Main Results) = report exposure-adjusted incidence or prevalence measures with appropriate confidence intervals when presenting risk measures/report details of interest, such as the mode of onset; *17 (Other Analyses) = report injury diagnosis information, including region and tissue type in tabular form. In Discussion, *18 (Key Results) = summarize key results with reference to study objectives; *19 (Limitations) = discuss limitations in the data collection and coding procedures adopted, including in relation to any risk measures calculated; *20 (Interpretation) = provide a cautious overall interpretation of results, considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence; *21 (Generalizability) = discuss the generalizability of the athlete study population, and health problem subgroups of interest, to broader athlete groups. In Other Information, *22 (Funding) = provide the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based; *23 (Ethics) = outline how individual athlete data privacy and confidentiality considerations were addressed, in line with the Declaration of Helsinki.